Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Grogan

Showing results (31-40 of 145) with videos related to

Pageof 15
Sort By:
Cancer Research|February 11, 1999
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignanciesW T Bellamy, L Richter, Y Frutiger, et al.
Diagnostic Immunology|January 1, 1986
Differentiation of chronic lymphocytic leukemia from other "well to intermediate differentiated" lymphoproliferative disorders by the mouse rosette assayM J Hicks, T M Grogan, K Fielder, et al.
Hematology/Oncology Clinics of North America|October 23, 1997
Follicular lymphomas: do histologic subtypes predict outcome?T P Miller, M LeBlanc, T M Grogan, et al.
The Journal of Investigative Dermatology|November 1, 1991
Reduction of murine cutaneous UVB-induced tumor-infiltrating T lymphocytes by dietary canthaxanthinJ A Rybski, T M Grogan, M Aickin, et al.
Leukemia|March 1, 1993
Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetenceA F List, C M Spier, T P Miller, et al.
American Journal of Obstetrics and Gynecology|May 1, 1982
Malignant pelvic lymphomaW E Crisp, E A Surwit, T M Grogan, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Suppression of human lymphoma development in the severe combined immune-deficient mouse by imexon therapyE M Hersh, T M Grogan, C Y Funk, et al.
Human Pathology|November 1, 1986
Immunophenotypes in "well-differentiated" lymphoproliferative disorders, with emphasis on small lymphocytic lymphomaC M Spier, T M Grogan, K Fielder, et al.
Cancer Treatment and Research|January 1, 1988
Immunologic approaches to the classification of non-Hodgkin's lymphomasT M Grogan, C M Spier, L C Richter, et al.
Leukemia & Lymphoma|December 1, 1993
NCAM (CD56)-positive malignant lymphomaW F Kern, C M Spier, T P Miller, et al.
Pageof 15

Showing results (31-40 of 145) with videos related to

Sort By:
Pageof 15
Cancer Research|February 11, 1999
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignanciesW T Bellamy, L Richter, Y Frutiger, et al.
Diagnostic Immunology|January 1, 1986
Differentiation of chronic lymphocytic leukemia from other "well to intermediate differentiated" lymphoproliferative disorders by the mouse rosette assayM J Hicks, T M Grogan, K Fielder, et al.
Hematology/Oncology Clinics of North America|October 23, 1997
Follicular lymphomas: do histologic subtypes predict outcome?T P Miller, M LeBlanc, T M Grogan, et al.
The Journal of Investigative Dermatology|November 1, 1991
Reduction of murine cutaneous UVB-induced tumor-infiltrating T lymphocytes by dietary canthaxanthinJ A Rybski, T M Grogan, M Aickin, et al.
Leukemia|March 1, 1993
Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetenceA F List, C M Spier, T P Miller, et al.
American Journal of Obstetrics and Gynecology|May 1, 1982
Malignant pelvic lymphomaW E Crisp, E A Surwit, T M Grogan, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Suppression of human lymphoma development in the severe combined immune-deficient mouse by imexon therapyE M Hersh, T M Grogan, C Y Funk, et al.
Human Pathology|November 1, 1986
Immunophenotypes in "well-differentiated" lymphoproliferative disorders, with emphasis on small lymphocytic lymphomaC M Spier, T M Grogan, K Fielder, et al.
Cancer Treatment and Research|January 1, 1988
Immunologic approaches to the classification of non-Hodgkin's lymphomasT M Grogan, C M Spier, L C Richter, et al.
Leukemia & Lymphoma|December 1, 1993
NCAM (CD56)-positive malignant lymphomaW F Kern, C M Spier, T P Miller, et al.
Pageof 15